ProtoKinetix

ProtoKinetix R&D Expenses

The Research & Development Expenses of ProtoKinetix (PKTX) as of Nov 19, 2026 is 106,613.00 USD. In the previous year, Research & Development Expenses was 99,625.00 USD — a change of 7.01% (higher).

R&D Expenses

106,613.00USD

YoY

7.01%

Last updated:

Research & Development Expenses of ProtoKinetix is 2025 106,613.00 USD. Research & Development Expenses of ProtoKinetix was 2024 99,625.00 USD. It decreases by 7.01% higher compared to the previous year.

The ProtoKinetix R&D Expenses history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

R&D Expenses
Date
R&D Expenses
Jan 1, 2018
337,067.00 USD
Jan 1, 2019
369,520.00 USD
Jan 1, 2020
527,291.00 USD
Jan 1, 2021
435,872.00 USD
Jan 1, 2022
448,873.00 USD
Jan 1, 2023
112,444.00 USD
Jan 1, 2024
99,625.00 USD
Jan 1, 2025
106,613.00 USD
The ProtoKinetix R&D Expenses history
YEARR&D ExpensesYoY
106,613.00USD+7.01%
99,625.00USD-11.40%
112,444.00USD-74.95%
448,873.00USD+2.98%
435,872.00USD-17.34%
527,291.00USD+42.70%
369,520.00USD+9.63%
337,067.00USD+13.68%
296,515.00USD-34.24%
450,899.00USD+183.78%
158,890.00USD+1,055.56%
13,750.00USD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

ProtoKinetix Stock analysis

What does ProtoKinetix do? ProtoKinetix Inc. is a Canadian biotechnology company focused on the development of glycoproteins for therapeutic applications. The company was founded in 2005 and is headquartered in Marietta, USA. ProtoKinetix specializes in the research and development of AAGP® (Anti-Aging Glycopeptide) as biopharmaceuticals. These proprietary glycoproteins have the ability to protect cells and can be used in various therapeutic applications for improving damage in physical injury, spinal cord injury, diabetes, transplantation, and retinal diseases. In addition to the medical field, ProtoKinetix is also developing its patented technology for use in bio-agriculture and animal healthcare. It has a subsidiary that holds the rights to use and distribute AAGP® and its patents. ProtoKinetix's business model involves licensing its glycoprotein technology for various applications, including biopharmaceuticals, bioprocessing industries, and cell protection management for regenerative medicine and stem cell preparations. The company has established partnerships with other biotech companies to integrate its AAGP® technology into their product pipelines. ProtoKinetix's flagship product is the AAGP® protein solution, which is used as a medication in regenerative medicine, organ transplantation, eye healing, and animal health. It is also interested in researching the application of AAGP® in crop farming to increase yields and improve soil quality. ProtoKinetix is poised to play a significant role in the development of glycoproteins as future medicines and therapeutic technologies in various industries. It not only has the potential to explore healing medical products but also aims to enhance agriculture and animal care. ProtoKinetix represents an excellent example of a biotechnology company focused on improving the healthcare and agricultural industries. ProtoKinetix is one of the most popular companies on Eulerpool.

Frequently Asked Questions about ProtoKinetix stock

Research & Development Expenses of ProtoKinetix is 106,613.00 USD in 2025.

Research & Development Expenses of ProtoKinetix changed from 99,625.00 USD to 106,613.00 USD, representing a 7.01% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Research & Development Expenses ProtoKinetix since 2006 – with annual values, charts, and detailed analysis.

R&D expenses represent the costs incurred in researching and developing new products, services, or processes. High R&D spending can signal innovation and future growth potential.

Research & Development Expenses's USD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Research & Development Expenses's ProtoKinetix historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Income Statement — ProtoKinetix

All Key Metrics — ProtoKinetix